Showing 13,781 - 13,800 results of 101,627 for search '(( i ae decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 13781
  2. 13782
  3. 13783
  4. 13784
  5. 13785
  6. 13786
  7. 13787
  8. 13788
  9. 13789
  10. 13790
  11. 13791

    Data from paper "<b>Selectively vulnerable deep cortical layer 5/6 fast-spiking interneurons in Alzheimer’s Disease models </b><b><i>in vivo</i></b>", Papanikolaou et al., Neuron 2... by Amalia Papanikolaou (20974103)

    Published 2025
    “…These dysfunctions occurred alongside a deep layer-specific reduction in neuronal pentraxin 2 (NPTX2) within excitatory neurons, decreased GluA4 in PV-FSIs, and fewer excitatory synapses onto PV-FSIs. …”
  12. 13792

    Structural Basis for Sequence Specific DNA Binding and Protein Dimerization of HOXA13 by Yonghong Zhang (20918)

    Published 2011
    “…I366 makes similar methyl contacts with T3* and T4*. Mutants (I366A, N370A and V373G) all have decreased DNA binding and transcriptional activity. …”
  13. 13793

    <i>Cotton Leaf Curl Multan virus</i> C4 protein suppresses both transcriptional and post-transcriptional gene silencing by interacting with SAM synthetase by Asigul Ismayil (5698946)

    Published 2018
    “…Plants infected with CLCuMuV carrying C4<sup>R13A</sup> show decreased levels of symptoms and viral DNA accumulation associated with enhanced viral DNA methylation. …”
  14. 13794

    Supplementary Material for: Hyperfunctioning Papillary Thyroid Carcinoma with a <b><i>BRAF</i></b> Mutation: The First Case Report and a Literature Review by Shinkai S. (10260734)

    Published 2021
    “…<b><i>Introduction:</i></b> Hyperfunctioning papillary thyroid carcinoma (PTC) is rare and consequently, little information on its molecular etiology is available. Although <i>BRAF</i> V600E (<i>BRAF</i> c.1799T>A, p.V600E) is a prominent oncogene in PTC, its mutation has not yet been reported in hyperfunctioning PTC. …”
  15. 13795

    Image_5_COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.TIF by Satoshi Nishiwaki (560641)

    Published 2021
    “…Similarly, the mean percentage change of reported results for each month in 2019 and 2020 was −5.1%, with the maximum of −27.4% observed in July 2020. …”
  16. 13796
  17. 13797
  18. 13798
  19. 13799

    Hemostatic abnormalities in COVID-19: A guided review by PLÍNIO C. SATHLER (10365401)

    Published 2021
    “…<div><p>Abstract The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 213 countries in a matter of weeks. …”
  20. 13800